This ticker has not been starred yet ILMN Illumina, Inc.
Laboratory Analytical Instruments
Book value per $ invested $ 0.11
Leverage 61.45%
Market Cap $ 21.7B
PE 30.88
Dividend Yield 0.00%
Profit $ 702.0m
Margin 15.73%

Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California.

Subscribe Now For Access - Only $1.99 Per Month